scholarly journals Central nervous system progression in advanced non–small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: a comparative study

BMC Cancer ◽  
2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Meng-Xia Li ◽  
Hao He ◽  
Zhi-Hua Ruan ◽  
Yu-Xi Zhu ◽  
Rong-Qing Li ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Central Nervous System ◽  
Small Cell ◽  
Egfr Mutations ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
Egfr Tkis ◽  
First Line Treatment

Survival Outcome of Inoperable Non-Small Cell Lung Cancer Patients Receiving Conventional Dose Epirubicin and Paclitaxel as First-Line Treatment

Oncology ◽  
2005 ◽  
Vol 68 (4-6) ◽  
pp. 350-355 ◽  
Author(s):  
Chih-Hsin Yang ◽  
Min-Chun Chen ◽  
Ann-Lii Cheng ◽  
Chih-Hung Hsu ◽  
Kun-Huei Yeh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Survival Outcome ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
Conventional Dose ◽  
First Line Treatment

scholarly journals Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases

2016 ◽  
Vol 12 (6) ◽  
pp. 4635-4642 ◽  
Author(s):  
Dimitra Stefanou ◽  
Sofia Stamatopoulou ◽  
Antigoni Sakellaropoulou ◽  
Gavriil Akakios ◽  
Marina Gkiaouraki ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document